Biomarkers (1)
- RIN Number - RNA integrity number of RNA sample (phv00167315.v1.p1)
Demographics (2)
- Age - Disease onset age (phv00167302.v1.p1)
- Gender - Gender of participant (phv00167303.v1.p1)
Disease Events (8)
- % Pattern Field - Percent of participant tumor specimen with grade 4 or 5 histology (phv00167318.v1.p1)
- Cancer Stage - Indicates extent or severity of participant's disease (phv00167305.v1.p1)
- Gleason Score - Composite score of histological grades of participant tumor reflecting severity of disease (phv00167316.v1.p1)
- Histologic Grade - Indicates level of cell differentiation of participant tumor (phv00167314.v1.p1)
- Primary Disease - Primary diagnosis of participant (phv00167304.v1.p1)
- PSA Pre-Operative - Participant's prostate-specific antigen level before tumor resection (phv00167306.v1.p1)
- Radiation Therapy - Indicates whether patient received radiation therapy for their cancer (phv00167307.v1.p1)
- TMPRSS2-ERG Fusion Status - TMPRSS2-ERG gene fusion status of participant tumor (phv00167317.v1.p1)
Other (16)
- ANALYTE_TYPE - Analyte Type (phv00167310.v1.p1)
- CONSENT - Consent group (phv00167293.v1.p1)
- Original Material Type - Type of material (phv00167311.v1.p1)
- SAMP_SOURCE - Source repository where samples originate (phv00167298.v1.p1)
- SAMPID - De-identified sample ID (phv00167308.v1.p1)
- SAMPID - Sample ID (phv00167297.v1.p1)
- Sample Zonal Origin - Anatomical zone of the prostate from which sample derived (phv00167313.v1.p1)
- SAMPLE_TYPE - Sample type (phv00167309.v1.p1)
- SAMPLE_USE - The type of experimental data associated with the sample instance (phv00167300.v1.p1)
- SOURCE_SAMPID - Sample ID used in the Source Repository (phv00167299.v1.p1)
- SOURCE_SUBJID - Subject source ID (phv00167295.v1.p1)
- SUBJ_SOURCE - Source of subject (phv00167294.v1.p1)
- SUBJID - De-identified subject ID (phv00167301.v1.p1)
- SUBJID - Subject ID (phv00167296.v1.p1)
- SUBJID - Subject ID (phv00167292.v1.p1)
- Tissue Site - Body site where sample was collected (phv00167312.v1.p1)